Aktiesnakken — Januar 2010
-
genmab. ASH OFC (konkuurent til FCR) dukker op http://professional.cancerconsultants.com/oncology_main_news.aspx?id=44453
-
-
ja man må sige at vi har mistet Hørning "gunst"
-
og spises 7,80...
-
Denne bør hjælpe med at give et indblik i hvor stort potentialet er:
http://clinicaltrials.gov/ct2/show/NCT00845741 -
(NGAL) Evaluation in Emergency Department (ED) All-Comers
-
Det er potentielt så sindsygt at det er svært at forstå...
-
mojn
-
Ja igår ved luk lå der godt 80K i skjult salg op til 7,70 mener jeg det var, så der er nok stadig lidt til salg derude
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind